로딩 중…
지수 로딩 중…
Zai Lab Limited
ZLAB· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CN
CN$18.18-0.49%
2026-08-03
Financials
Valuation Metrics
Zai Lab Limited's Market Cap is $2.04B. At end of 2025 it was $1.95B. Ranked #2039 of 3,112 in US market (top 66%), #777 of 1,445 on NASDAQ (top 54%), #132 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 49%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.04B | US#2,039/3,112 Sec#132/269 |
| Revenue | $453M | US#2,393/3,112 Sec#82/269 |
| Net Income | $-178M | US—/3,112 Sec—/269 |
| Total Assets | $1.10B | US#2,409/3,112 Sec#93/269 |
| Net Assets | $662M | US#2,057/3,112 Sec#82/269 |
| Value | ||
| P/B | 3.09x | US#1,706/3,112 Sec#89/269 |
| P/S | 4.51x | US#2,184/3,112 Sec#72/269 |
| FCF Yield | -6.33% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -26.91% | US#2,588/3,112 Sec#118/269 |
| ROA | -16.26% | US#2,734/3,112 Sec#114/269 |
| Op. Margin | -53.48% | US#2,774/3,112 Sec#114/269 |
| Revenue Growth | -6.46% | US#2,563/3,112 Sec#139/269 |
| Financial Health | ||
| Debt Ratio | 65.52% | US#727/3,112 Sec#151/269 |
| Total Debt | $232M | US#2,135/3,112 Sec#86/269 |
| FCF | $-129M | US#2,641/3,112 Sec#172/269 |
| Cash | $651M | US#906/3,112 Sec#43/269 |
| Current Ratio | 2.40x | US#1,040/3,112 Sec#215/269 |
| Performance | ||
| 1Y Return | -50.62% | US#2,993/3,112 Sec#250/269 |
| 1M Return | -4.92% | US#2,229/3,112 Sec#125/269 |
| From 52W High | -54.14% | US#2,853/3,112 Sec#229/269 |
| 1Y MDD | -62.12% | US#2,773/3,112 Sec#221/269 |
| Trading | ||
| Volume | 314,160 shares | US#2,387/3,112 Sec#232/269 |
| Trading Value | $6M | US#2,622/3,112 Sec#215/269 |